Lillethorup Ida Aaberg, Hemmingsen Andreas Victor, Qvortrup Katrine
Department of Chemistry, Technical University of Denmark 2800 Kongens Lyngby Denmark
RSC Med Chem. 2025 Jan 17;16(3):1037-1048. doi: 10.1039/d4md00788c. eCollection 2025 Mar 19.
Prodrugs are masked drugs that first become pharmacologically active after undergoing a structural change . They are designed to improve physicochemical/biopharmaceutical drug properties and increase site specificity. The prodrug approach is important when developing brain-targeting drugs due to the presence of the brain barriers that seriously limit the brain entry of highly polar, multifunctional drug entities. While several excellent reviews summarize the structural modifications facilitating transport across the brain barriers, a summary of mechanisms used for the activation of the prodrug in the brain is missing. Given the high need for innovative discoveries in brain drug development, we here review the most important tools being developed since 2000 for CNS prodrug activation.
前药是经过结构变化后才具有药理活性的掩蔽型药物。它们旨在改善药物的物理化学/生物药剂学性质,并提高靶向性。由于血脑屏障的存在严重限制了高极性、多功能药物实体进入大脑,因此在前药研发脑靶向药物时,前药方法至关重要。虽然已有几篇优秀综述总结了促进药物透过血脑屏障的结构修饰,但缺少对前药在脑内激活机制的总结。鉴于脑药物研发对创新发现的迫切需求,我们在此综述了2000年以来开发的用于中枢神经系统前药激活的最重要工具。